Rheumatoid arthritis. Seropositive rheumatoid arthritis
Conditions
Interventions
Intervention 1: two placebo tablet per day for 3 months. Intervention 2: Bromocriptin oral pills 2.5 mg two tablet per day for 3 months.
Placebo
Treatment - Drugs
two placebo tablet per day for 3 months
Bromocriptin oral pills 2.5 mg two tablet per day for 3 months
Sponsors
Vice chancellor of research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Rheumatoid arthritis patients (proved by ACR criteria) that greater than 16 years old with active R.A (DAS>4) despite conventional thrapy. Exclusion criteria: Drug reaction, lapse from the study, Immigration or death, containdications for bromocriptin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical and laboratory findings. Timepoint: Before the study and 3 months later. Method of measurement: DAS28, ESR, VAS, Prolactin. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMansour Salesi
Isfahan University of Medical Sciences
Outcome results
None listed